Revisiting idiopathic eosinophilic myositis: towards a clinical-pathological continuum from the muscle to the fascia and skin
Authors:
- Cécile FermonCFCécile Fermon
- Lola E R LessardLLLola E R Lessard
- Tanguy FenouilTFTanguy Fenouil
- Alain MeyerAMAlain Meyer
- Marie Faruch-BilfeldMFMarie Faruch-Bilfeld
- Marie RobertMRMarie Robert
- Verena LandelVLVerena Landel
- François-Jérôme AuthierFAFrançois-Jérôme Authier
- Nathalie StreichenbergerNSNathalie Streichenberger
- Laure GallayLGLaure Gallay
Open Access
- 6 October 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 62 (6) , 2220-2229
Abstract
Idiopathic inflammatory myopathies are mainly defined by inflammatory infiltrates within the muscle (lymphocytes and macrophages). Eosinophil muscle infiltration has been described in idiopathic eosinophilic myositis (IEM) and rarely in EF. This study aimed to further delineate the nosological frame of idiopathic eosinophil muscle infiltration through the exhaustive analysis of IEM and EF patients. This multicentre retrospective case series included IEM patients diagnosed between 2000 and 2022. IEM inclusion criteria were eosinophilic muscle infiltration with myositis pathological features, after the exclusion of differential diagnoses. An additional group of EF patients diagnosed between 2016 and 2022 was constituted. Inclusion criteria were an EF diagnosis and fascia thickening with inflammatory infiltrate. A total of 20 IEM cases and 10 EF cases were included. The median (interquartile range) age at diagnosis was 65 (49–70) years; there were 18 males. Data analysis delineated four subgroups: focal EM (FEM, n = 3), diffuse EM (DEM, n = 6), eosinophilic myofasciitis (EMF, n = 11) and EF (n = 10). FEM represented a limited and benign form of myositis. DEM cases presented objective muscle impairment with eosinophilic muscle infiltration. EMF patients presented subjective muscle impairment (myalgia, 55%), fasciitis (on histology and/or imaging), eosinophilic muscle infiltration and frequent hypereosinophilia (55%). EF patients presented myalgia (50%), muscle lesions on histology with fascia-restricted inflammatory infiltrates with (60%) or without (40%) eosinophils. The analysis of IEM and EF patient characteristics delineates four subgroups (FEM, DEM, EMF and EF) in terms of clinical, laboratory, imaging, pathological and outcome specificities, and proposes an adapted diagnostic and care management approach.Keywords
Funding Information
- Association Française contre les Myopathies (#19507)
- Association Française contre les Myopathies (#23652)
This publication has 26 references indexed in Scilit:
- Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromesJournal of Allergy and Clinical Immunology, 2012
- Pathogenic aspects of dermatomyositis, polymyositis and overlap myositisLa Presse Médicale, 2011
- Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological formsJournal of Clinical Pathology, 2009
- MRI findings of muscle involvement in idiopathic hypereosinophilic syndromeEuropean Radiology, 1999
- Eosinophilic Myositis With Eosinophilic Cellulitislike Skin LesionsArchives of Dermatology, 1997
- The spectrum of eosinophilic myositisArthritis & Rheumatism, 1993
- Fasciitis, perimyositis, myositis, polymyositis, and eosinophiliaMuscle & Nerve, 1990
- The Idiopathic Hypereosinophilic SyndromeAnnals of Internal Medicine, 1982
- Eosinophilic polymyositisAnnals of Neurology, 1977
- THE HYPEREOSINOPHILIC SYNDROMEMedicine, 1975